title: Glimepiride treatment and IGF-I in adolescents with type 1 diabetes: a prospective, randomized, double-blind, placebo-controlled study.
authors.forename: Stefan A
authors.initials: SA
authors.lastname: Wudy
authors.forename: Josef
authors.initials: J
authors.lastname: Högel
authors.forename: Barbara
authors.initials: B
authors.lastname: Dollinger
authors.forename: Primus
authors.initials: P
authors.lastname: Mullis
authors.forename: Eberhard
authors.initials: E
authors.lastname: Heinze
mesh_terms: D000293:Adolescent; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D010919:Placebos; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
chemical_list: D018972:Insulin-Like Growth Factor Binding Protein 3; D010919:Placebos; D013453:Sulfonylurea Compounds; D007334:Insulin-Like Growth Factor I; C057619:glimepiride